Patent Assignment
Reel/Frame 037767/0417
Assignment of Assignor's Interest
Recorded: 2016-02-18
Pages: 11
Assignors
REYNOLDS, JOSEPH G.
Executed: 2013-09-03
OLIVIER, JOSEPH G., JR.
Executed: 2013-08-28
HENDRIKS, BART S.
Executed: 2013-09-03
WICKHAM, THOMAS
Executed: 2013-09-03
KLINZ, STEPHAN
Executed: 2013-08-28
GERETTI, ELENA
Executed: 2013-09-03
Assignee
MERRIMACK PHARMACEUTICALS, INC.
ONE KENDALL SQUARE, SUITE B7201, CAMBRIDGE, MASSACHUSETTS, 02139-1670
Covered Properties
(2)
Dosage and Administration for Preventing Cardiotoxicity in Treatment with ERBB2-Targeted Immunoliposomes Comprising Anthracycline Chemotherapeutic Agents
Application:
14/831,199 →
Publication:
US 2016/0038416
Dosage and Administration for Preventing Cardiotoxicity in Treatment with ERBB2-Targeted Immunoliposomes Comprising Anthracycline Chemotherapeutic Agents
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest
Dec 28, 2015
From: MERRIMACK PHARMACEUTICALS, INC.
To: U.S. BANK NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 037394/0285 →
Corrective Assignment to Correct the Second Assignor's Name Previously Recorded at Reel: 037767 Frame: 0417. Assignor(S) Hereby Confirms the Assignment.
Feb 16, 2017
From: REYNOLDS, JOSEPH G.; OLIVIER, KENNETH J., JR.; HENDRIKS, BART S.; WICKHAM, THOMAS
To: MERRIMACK PHARMACEUTICALS, INC.
Reel/Frame 041850/0456 →
Release of Security Interest
Apr 14, 2017
From: U.S. BANK NATIONAL ASSOCIATION
To: MERRIMACK PHARMACEUTICALS, INC.
Reel/Frame 042254/0349 →